Disease burden associated with influenza activity at the population level
Epidemiology and Infection · 2026 · 154
DOI: 10.1017/s0950268826101320 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epidemiology and Infection, online erschienen am 06.04.2026. Verfasst von Aaron C Miller und 8 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, https://ror.org/036jqmy94The University of Iowa Roy J and Lucille A Carver College of Medicine, USA. Hauptthemen laut MEDLINE: Influenza, Human, Cost of Illness. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer Foundation.
Abstract (Originalsprache)
Influenza increases the risk of secondary diseases, but other than pneumonia, many of these diseases (e.g., sinusitis, otitis media, acute myocardial infarctions) are not consistently considered in estimates of influenza burden. We used the Merative Marketscan database (2001–2019) and time-series methods to identify age-specific categories of diseases that were temporally associated with patterns of influenza activity. Next, we estimated hypothetical reductions in the incidence and costs of these diseases if influenza incidence were reduced. Of 282 different disease categories evaluated, 23 (8.2%) were strongly associated with influenza (e.g., acute bronchitis, otitis media, myocardial infarctions, sinusitis, COPD) in at least one age group. For example, we estimated a 20% decrease in peak influenza incidence could decrease acute bronchitis cases by 6.5% and pneumonia cases by 5.3%, corresponding to a $1.6 billion reduction in healthcare costs. Excluding secondary diseases associated with influenza may lead to substantial underestimates of influenza’s burden and costs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Internal Medicine, https://ror.org/036jqmy94The University of Iowa Roy J and Lucille A Carver College of Medicine, USA.
- Biostatistics, https://ror.org/036jqmy94The University of Iowa College of Public Health, USA.
- https://ror.org/059g90c15Pfizer Canada ULC, Canada.
- https://ror.org/01xdqrp08Pfizer Inc, USA.
ORCID-Profile: Philip M Polgreen
Förderung
- Pfizer Foundation
Zitieren
APA
Miller, A. C., Boonstra, D. E., Cavanaugh, J. E., Boikos, C., Hu, T., McLaughlin, J., Weimken, T., Welch, V., & Polgreen, P. M. (2026). Disease burden associated with influenza activity at the population level. Epidemiology and Infection, 154. https://doi.org/10.1017/s0950268826101320
Vancouver
Miller AC, Boonstra DE, Cavanaugh JE, Boikos C, Hu T, McLaughlin J, et al. Disease burden associated with influenza activity at the population level. Epidemiology and Infection. 2026;154. doi:10.1017/s0950268826101320
BibTeX
@article{Miller2026,
author = {Miller, Aaron C and Boonstra, Daniel Erik and Cavanaugh, Joseph E and Boikos, Constantina and Hu, Tianyan and McLaughlin, John and Weimken, Timothy and Welch, Verna and Polgreen, Philip M},
title = {Disease burden associated with influenza activity at the population level},
journal = {Epidemiology and Infection},
year = {2026},
volume = {154},
doi = {10.1017/s0950268826101320}
}
EUVIMED